Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

4.81
BATS BZX Real-Time Price
As of 12:12pm ET
 -0.15 / -3.02%
Today’s Change
3.60
Today|||52-Week Range
7.03
-22.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$469.4M

Company Description

Cerus Corp. is a biomedical products company, which is engaged in developing and commercializing the INTERCEPT blood system. It currently markets and sells the INTERCEPT blood system for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Contact Information

Cerus Corp.
2550 Stanwell Drive
Concord California 94520
P:(925) 288-6000
Investor Relations:
(925) 288-6319

Employees

Shareholders

Individual stakeholders5.01%
Other institutional44.27%
Mutual fund holders28.39%

Top Executives

William Mariner GreenmanPresident, Chief Executive Officer & Director
Suzanne MargerumVice President-Manufacturing & Operations
Kevin Dennis GreenChief Financial Officer & Vice President
Laurence M. CorashDirector, Chief Scientific Officer & Senior VP
Adonis StassinopoulosVP-Global Scientific Affairs & Research